{"id":"https://openalex.org/W4392687374","doi":"https://doi.org/10.1158/0008-5472.c.6506871.v1","title":"Data from Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b","display_name":"Data from Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392687374","doi":"https://doi.org/10.1158/0008-5472.c.6506871.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6506871.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506871.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6506871.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6506871.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113057203","display_name":"Aksana Vasilyeva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aksana Vasilyeva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010596311","display_name":"Selvi Durmu\u015f","orcid":"https://orcid.org/0000-0003-3792-1607","observed_orcids":["https://orcid.org/0000-0003-3792-1607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Selvi Durmus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016647580","display_name":"Lie Li","orcid":"https://orcid.org/0000-0003-1508-5484","observed_orcids":["https://orcid.org/0000-0003-1508-5484"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lie Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050563360","display_name":"Els Wagenaar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Els Wagenaar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068080699","display_name":"Alice A. Gibson","orcid":"https://orcid.org/0000-0001-5910-5067","observed_orcids":["https://orcid.org/0000-0001-5910-5067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice A. Gibson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039997334","display_name":"John Carl Panetta","orcid":"https://orcid.org/0000-0003-1308-7208","observed_orcids":["https://orcid.org/0000-0003-1308-7208"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Panetta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054253771","display_name":"Sridhar Mani","orcid":"https://orcid.org/0000-0003-4132-6157","observed_orcids":["https://orcid.org/0000-0003-4132-6157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sridhar Mani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5045217576","display_name":"Alfred H. Schinkel","orcid":"https://orcid.org/0000-0002-4215-8602","observed_orcids":["https://orcid.org/0000-0002-4215-8602"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfred H. Schinkel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.8740000128746033},{"id":"https://openalex.org/keywords/abcc3","display_name":"ABCC3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hepatic-glucuronidation","display_name":"hepatic glucuronidation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/drug-detoxification","display_name":"drug detoxification","score":0.5920000076293945},{"id":"https://openalex.org/keywords/intestinal-reabsorption","display_name":"intestinal reabsorption","score":0.6290000081062317},{"id":"https://openalex.org/keywords/drug-reabsorption","display_name":"drug reabsorption","score":0.4009999930858612},{"id":"https://openalex.org/keywords/anticancer-drug-metabolism","display_name":"anticancer drug metabolism","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.880224347114563},{"id":"https://openalex.org/C36201501","wikidata":"https://www.wikidata.org/wiki/Q17907816","display_name":"Multidrug resistance-associated protein 2","level":5,"score":0.6863507628440857},{"id":"https://openalex.org/C2779186261","wikidata":"https://www.wikidata.org/wiki/Q137786","display_name":"Glucuronide","level":3,"score":0.5681296586990356},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.4149583578109741},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39484772086143494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29467859864234924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22048699855804443},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.0972180962562561},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07978889346122742},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.06819608807563782},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0660339891910553},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6506871.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506871.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6506871.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6506871.v1","doi":"https://doi.org/10.1158/0008-5472.c.6506871.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6506871.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1544537424","https://openalex.org/W2611065138","https://openalex.org/W7096532687","https://openalex.org/W2152540368","https://openalex.org/W2037527490","https://openalex.org/W2055275875","https://openalex.org/W4361944564","https://openalex.org/W2317722301","https://openalex.org/W3203193755","https://openalex.org/W4246401500"],"abstract_inverted_index":{"Abstract":[0],"Recently,":[1],"an":[2],"efficient":[3],"liver":[4,43],"detoxification":[5,152],"process":[6,142],"dubbed":[7],"\u201chepatocyte":[8,145],"hopping\u201d":[9],"was":[10],"proposed":[11],"on":[12],"the":[13,18,54,78,85,111,130],"basis":[14],"of":[15,50,138,153],"findings":[16],"with":[17],"endogenous":[19],"compound,":[20],"bilirubin":[21,28],"glucuronide.":[22],"According":[23],"to":[24,120],"this":[25],"model,":[26],"hepatocytic":[27],"glucuronide":[29,48],"can":[30,58,72,93,114],"follow":[31],"a":[32,139],"liver-to-blood":[33],"shuttling":[34,141],"loop":[35],"via":[36],"Abcc3":[37],"transporter-mediated":[38],"efflux":[39],"and":[40,90],"subsequent":[41],"Oatp1a/1b-mediated":[42],"uptake.":[44],"We":[45,104],"hypothesized":[46],"that":[47,70,91,107,157],"conjugates":[49],"xenobiotics,":[51],"such":[52,161],"as":[53,144,162],"anticancer":[55],"drug":[56],"sorafenib,":[57,121],"also":[59],"undergo":[60,158],"hepatocyte":[61,140],"hopping.":[62],"Using":[63],"transporter-deficient":[64],"mouse":[65],"models,":[66],"we":[67],"show":[68],"here":[69],"sorafenib-glucuronide":[71,108],"be":[73,94,115],"extruded":[74],"from":[75],"hepatocytes":[76,101],"into":[77,84,99,110],"bile":[79],"by":[80,88,102,117],"Abcc2":[81],"or":[82],"back":[83],"systemic":[86,131],"circulation":[87],"Abcc3,":[89],"it":[92],"taken":[95],"up":[96],"efficiently":[97],"again":[98],"neighboring":[100],"Oatp1a/1b.":[103],"further":[105],"demonstrate":[106],"excreted":[109],"gut":[112],"lumen":[113],"cleaved":[116],"microbial":[118],"enzymes":[119],"which":[122],"is":[123],"then":[124],"reabsorbed,":[125],"supporting":[126],"its":[127],"persistence":[128],"in":[129,149],"circulation.":[132],"Our":[133],"results":[134],"suggest":[135],"broad":[136],"relevance":[137],"known":[143],"hopping\u201d\u2014a":[146],"novel":[147],"concept":[148],"clinical":[150],"pharmacology\u2014for":[151],"targeted":[154],"cancer":[155],"drugs":[156],"hepatic":[159],"glucuronidation,":[160],"sorafenib.":[163],"Cancer":[164],"Res;":[165],"75(13);":[166],"2729\u201336.":[167],"\u00a92015":[168],"AACR.":[169]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2024-03-13T00:00:00"}
